The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting ...
Eli Lilly has stepped into the gene therapy space after announcing a deal to acquire Prevail Therapeutics, a company focused on developing adeno-associated virus (AAV)-based gene therapies for ...
A supplemental New Drug Application (sNDA) for Pfizer’s Talzenna (talazoparib) in combination with Xtandi (enzalutamide) has ...
Trixeo/Breztri, is approved in the US for treatment of asthma, with regulatory filings currently under review in other major ...
AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...
Veradermics has announced positive topline results from its open-label phase 2 clinical trial (Study ‘207’) evaluating ...
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than ...
Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each ...
Almirall’s submission to extend its Marketing Authorisation Application (MAA) for Ebglyss (lebrikizumab) to treat moderate-to ...
Takeda has announced new data from the two pivotal phase 3 studies of zasocitinib (TAK-279) in adults with moderate-to-severe ...
ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, has appointed Hitesh ...
The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results